A promising method for mixed population genotyping of drug-resistant HIV-1

被引：0
|
作者：
Moser, MJ
Beaty, EL
Ruckstuhl, M
Kozlowski, M
Schinazi, RF
Prudent, JR
机构：
[1] EraGen Biosci, Madison, WI USA
[2] Emory Univ, VA Med Ctr, Decatur, GA 30033 USA
来源：
ANTIVIRAL THERAPY | 2005年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [41] CHARACTERIZATION OF DRUG-RESISTANT STRAINS OF HIV-1 SELECTED EITHER INVIVO OR INVITRO
    WAINBERG, MA
    GAO, Q
    LVOVICH, A
    PARNIAK, MA
    BEAULIEU, R
    MONTANER, JSG
    RUEDY, J
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (05) : 865 - 865
  • [42] IFN-lambda Inhibits Drug-Resistant HIV-1 Infection of Macrophages
    Wang, X.
    Liu, M-Q
    Peng, J-S
    Li, J-L
    Wang, Y-Z
    Zhou, Y.
    Zhou, W.
    Ho, W-Z
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2015, 10 : S107 - S107
  • [43] HIV-1 Diversity and Drug-Resistant Mutations in Infected Individuals in Changchun, China
    Yan, Ming
    Zhao, Ke
    Du, Juan
    Li, Linzhang
    Wu, Donglin
    Xu, Shengming
    Zeng, Xiangchao
    Wang, Guanjun
    Yu, Xiao-Fang
    PLOS ONE, 2014, 9 (06):
  • [44] Divergent distribution of HIV-1 drug-resistant variants on and off antiretroviral therapy
    Venturi, G
    Romano, L
    Carli, T
    Corsi, P
    Pippi, L
    Valensin, PE
    Zazzi, M
    ANTIVIRAL THERAPY, 2002, 7 (04) : 245 - 250
  • [45] Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia
    Lazzarin, A
    Clotet, B
    Cooper, D
    Reynes, J
    Arasteh, K
    Nelson, M
    Katlama, C
    Stellbrink, H
    Delfraissy, J
    Lange, J
    Huson, L
    DeMasi, R
    Wat, C
    Delehanty, J
    Drobnes, C
    Salgo, M
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (22): : 2186 - 2195
  • [46] Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants
    Smith, Steven J.
    Zhao, Xue Zhi
    Burke, Terrence R., Jr.
    Hughes, Stephen H.
    RETROVIROLOGY, 2018, 15
  • [47] Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants
    Steven J. Smith
    Xue Zhi Zhao
    Terrence R. Burke
    Stephen H. Hughes
    Retrovirology, 15
  • [48] HIV-1 Integrase Inhibitors That Are Active against Drug-Resistant Integrase Mutants
    Smith, Steven J.
    Zhao, Xue Zhi
    Passos, Dario Oliveira
    Lyumkis, Dmitry
    Burke, Terrence R., Jr.
    Hughes, Stephen H.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (09)
  • [49] Transmission of drug-resistant HIV-1 in Europe remains limited to single classes
    Wensing, Annemarie M. J.
    Vercauteren, Jurgen
    van de Vijver, David A.
    Albert, Jan
    Asjo, Birgitta
    Balotta, Claudia
    Camacho, Ricardo
    Coughlan, Suzie
    Grossman, Zehava
    Horban, Andrzej
    Kucherer, Claudia
    Nielsen, Claus
    Paraskevis, Dimitris
    Loke, Wei C.
    Poggensee, Gabrielle
    Puchhammer-Stockl, Elisabeth
    Riva, Chiara
    Ruiz, Lidia
    Schmit, Jean-Claude
    Schuurman, Rob
    Salminen, Mika
    Sonnerborg, Anders
    Stanojevic, Maja
    Struck, Daniel
    Vandamme, Anne-Mieke
    Boucher, Charles A. B.
    AIDS, 2008, 22 (05) : 625 - 635
  • [50] Should patients with drug-resistant HIV-1 continue to receive antiretroviral therapy?
    Frenkel, LM
    Mullins, JI
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (07): : 520 - 522
12345